Report Update Nov 1, 2024

CIS - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

CIS: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Exports

Exports in CIS

After two years of growth, overseas shipments of medicaments containing insulin but not antibiotics decreased by -12.7% to X kg in 2021. Over the period under review, exports, however, enjoyed strong growth. The most prominent rate of growth was recorded in 2020 with an increase of 1,186%. As a result, the exports attained the peak of X kg, and then contracted in the following year.

In value terms, medicaments containing insulin exports declined to $X in 2021. In general, exports, however, enjoyed noticeable growth. The growth pace was the most rapid in 2020 when exports increased by 886%. The level of export peaked at $X in 2016; however, from 2017 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

Russia (X kg) represented roughly 100% of total exports in 2021.

Russia was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of +8.0% from 2012 to 2021. The shares of the largest exporters remained relatively stable throughout the analyzed period.

In value terms, Russia ($X) also remains the largest medicaments containing insulin supplier in the CIS.

In Russia, medicaments containing insulin exports increased at an average annual rate of +4.0% over the period from 2012-2021.

Export Prices by Country

In 2021, the export price in the CIS amounted to $X per ton, almost unchanged from the previous year. In general, the export price, however, continues to indicate a pronounced contraction. The most prominent rate of growth was recorded in 2015 an increase of 37% against the previous year. The level of export peaked at $X per ton in 2016; however, from 2017 to 2021, the export prices stood at a somewhat lower figure.

As there is only one major export destination, the average price level is determined by prices for Russia.

From 2012 to 2021, the rate of growth in terms of prices for Russia amounted to -3.6% per year.

Medicaments Containing Insulin Imports

Imports in CIS

Medicaments containing insulin imports dropped notably to X tons in 2021, reducing by -73.4% against the previous year's figure. Overall, imports faced a precipitous shrinkage. The growth pace was the most rapid in 2016 with an increase of 317%. The volume of import peaked at X tons in 2013; however, from 2014 to 2021, imports remained at a lower figure.

In value terms, medicaments containing insulin imports dropped significantly to $X in 2021. In general, imports faced a significant decline. The most prominent rate of growth was recorded in 2016 with an increase of 302%. The level of import peaked at $X in 2018; however, from 2019 to 2021, imports failed to regain momentum.

Imports by Country

Russia represented the key importer of medicaments containing insulin but not antibiotics in the CIS, with the volume of imports accounting for X tons, which was approx. 88% of total imports in 2021. It was distantly followed by Belarus (X kg), comprising an 11% share of total imports.

Imports into Russia decreased at an average annual rate of -41.8% from 2012 to 2021. At the same time, Belarus (+35.1%) displayed positive paces of growth. Moreover, Belarus emerged as the fastest-growing importer imported in the CIS, with a CAGR of +35.1% from 2012-2021. Belarus (+11 p.p.) significantly strengthened its position in terms of the total imports, while Russia saw its share reduced by -11.5% from 2012 to 2021, respectively.

In value terms, Russia ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in the CIS, comprising 100% of total imports. The second position in the ranking was taken by Belarus ($X), with a 0.1% share of total imports.

In Russia, medicaments containing insulin imports plunged by an average annual rate of -27.6% over the period from 2012-2021.

Import Prices by Country

In 2021, the import price in the CIS amounted to $X per ton, increasing by 38% against the previous year. Overall, the import price saw significant growth. The pace of growth appeared the most rapid in 2020 an increase of 123%. Over the period under review, import prices hit record highs in 2021 and is likely to continue growth in years to come.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Russia ($X per ton), while Belarus stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Russia (+24.4%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the CIS?

The country with the largest volume of medicaments containing insulin consumption was Russia, accounting for 100% of total volume.

What are the leading exporters of medicaments containing insulin but not antibiotics in the CIS?

In value terms, Russia remains the largest medicaments containing insulin supplier in the CIS.

What are the leading importers of medicaments containing insulin but not antibiotics in the CIS?

In value terms, Russia constitutes the largest market for imported medicaments containing insulin but not antibiotics in the CIS.

What is the average export price for medicaments containing insulin but not antibiotics in the CIS?

In 2020, the medicaments containing insulin export price in the CIS amounted to $187,155 per ton, declining by -23.4% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in the CIS?

In 2020, the medicaments containing insulin import price in the CIS amounted to $1,729 per kg, growing by 12% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in CIS. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Armenia
Azerbaijan
Belarus
Kazakhstan
Kyrgyzstan
Moldova
Russia
Tajikistan
Uzbekistan

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Production in CIS, split by region and country
Trade (exports and imports) in CIS
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. CONSUMPTION BY COUNTRY
3. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
2. PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
11. COUNTRY PROFILES

The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO
- Armenia
- Azerbaijan
- Belarus
- Kazakhstan
- Kyrgyzstan
- Moldova
- Russia
- Tajikistan
- Uzbekistan
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption, By Country, 2018–2023
5. Production, In Physical Terms, By Country, 2012–2023
6. Imports, In Physical Terms, By Country, 2012–2023
7. Imports, In Value Terms, By Country, 2012–2023
8. Import Prices, By Country Of Destination, 2012–2023
9. Exports, In Physical Terms, By Country, 2012–2023
10. Exports, In Value Terms, By Country, 2012–2023
11. Export Prices, By Country Of Origin, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Consumption, By Country, 2023
4. Market Volume Forecast to 2030
5. Market Value Forecast to 2030
6. Products: Market Size And Growth, By Type
7. Products: Average Per Capita Consumption, By Type
8. Products: Exports And Growth, By Type
9. Products: Export Prices And Growth, By Type
10. Production Volume And Growth
11. Exports And Growth
12. Export Prices And Growth
13. Market Size And Growth
14. Per Capita Consumption
15. Imports And Growth
16. Import Prices
17. Production, In Physical Terms, 2012–2023
18. Production, In Value Terms, 2012–2023
19. Production, By Country, 2023
20. Production, In Physical Terms, By Country, 2012–2023
21. Imports, In Physical Terms, 2012–2023
22. Imports, In Value Terms, 2012–2023
23. Imports, In Physical Terms, By Country, 2023
24. Imports, In Physical Terms, By Country, 2012–2023
25. Imports, In Value Terms, By Country, 2012–2023
26. Import Prices, By Country, 2012–2023
27. Exports, In Physical Terms, 2012–2023
28. Exports, In Value Terms, 2012–2023
29. Exports, In Physical Terms, By Country, 2023
30. Exports, In Physical Terms, By Country, 2012–2023
31. Exports, In Value Terms, By Country, 2012–2023
32. Export Prices, 2012–2023